Literature DB >> 18777202

Intracellular delivery of heparin complexed with chitosan-g-poly(ethylene glycol) for inducing apoptosis.

Ki Hyun Bae1, Chang Won Moon, Yuhan Lee, Tae Gwan Park.   

Abstract

PURPOSE: Chitosan-g-PEG/heparin polyelectrolyte complex micelles were prepared for inducing apoptotic death of cancer cells.
MATERIALS AND METHODS: The cytotoxicity of polyelectrolyte complex micelles was evaluated by examining the growth inhibition of mouse melanoma B16F10 cells. Cellular uptake and apoptosis-inducing effect were investigated by confocal laser scanning microscopy and flow cytometric analysis, respectively.
RESULTS: The prepared polyelectrolyte complex micelles had a spherical shape with an average diameter of 162.8 +/- 18.9 nm. They were highly stable and well dispersed even in the presence of serum due to the presence of hydrophilic PEG shell layer surrounding the micelles. Moreover, they exhibited significantly higher cytotoxic activity against B16F10 cells compared to heparin or chitosan-g-PEG at the same concentration. The polyelectrolyte complex micelles were internalized by cancer cells to a greater extent than free heparin alone, indicating that the dramatic cell death was attributed to the increased cellular uptake of heparin. The internalized heparin was shown to induce apoptotic death of the cancer cells via a caspase-dependent pathway.
CONCLUSIONS: Nanosized and stable chitosan-g-PEG/heparin polyelectrolyte complex micelles were produced by a self-assembly process. The polyelectrolyte complex micelles facilitated the intracellular delivery of heparin, triggered the caspase activation, and consequently promoted apoptotic death of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777202     DOI: 10.1007/s11095-008-9713-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

Review 1.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

2.  Materials science. Enhancing drug function.

Authors:  Jeffrey A Hubbell
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

Review 3.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery.

Authors:  Sunil A Agnihotri; Nadagouda N Mallikarjuna; Tejraj M Aminabhavi
Journal:  J Control Release       Date:  2004-11-05       Impact factor: 9.776

4.  Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.

Authors:  Yu-Hsin Lin; Fwu-Long Mi; Chiung-Tong Chen; Wei-Chun Chang; Shu-Fen Peng; Hsiang-Fa Liang; Hsing-Wen Sung
Journal:  Biomacromolecules       Date:  2007-01       Impact factor: 6.988

5.  Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Authors:  L Borsig; R Wong; J Feramisco; D R Nadeau; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Folate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosis.

Authors:  Kyung Chul Cho; Ji Hoon Jeong; Hyun Jung Chung; Cheol O Joe; Sung Wan Kim; Tae Gwan Park
Journal:  J Control Release       Date:  2005-09-01       Impact factor: 9.776

7.  Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.

Authors:  Shirui Mao; Michael Neu; Oliver Germershaus; Olivia Merkel; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel
Journal:  Bioconjug Chem       Date:  2006 Sep-Oct       Impact factor: 4.774

8.  The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative.

Authors:  Kyeongsoon Park; Seok Ki Lee; Dai Hyun Son; Soo Ah Park; Kwangmeyung Kim; Hyo Won Chang; Eun-Jeong Jeong; Rang-Woon Park; In-San Kim; Ick Chan Kwon; Youngro Byun; Sang Yoon Kim
Journal:  Biomaterials       Date:  2007-03-01       Impact factor: 12.479

9.  Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.

Authors:  Mi Kyung Yu; Dong Yun Lee; Yoo Shin Kim; Kyeongsoon Park; Soo Ah Park; Dai Hyun Son; Gee Young Lee; Jong Hee Nam; Sang Yoon Kim; In San Kim; Rang Woon Park; Youngro Byun
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

10.  Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death.

Authors:  David Berry; David M Lynn; Ram Sasisekharan; Robert Langer
Journal:  Chem Biol       Date:  2004-04
View more
  5 in total

Review 1.  Electrostatic surface modifications to improve gene delivery.

Authors:  Ron B Shmueli; Daniel G Anderson; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Reversible maleimide-thiol adducts yield glutathione-sensitive poly(ethylene glycol)-heparin hydrogels.

Authors:  Aaron D Baldwin; Kristi L Kiick
Journal:  Polym Chem       Date:  2013-01-07       Impact factor: 5.582

3.  Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study.

Authors:  Alyaa Ramadan; Frederic Lagarce; Anne Tessier-Marteau; Olivier Thomas; Pierre Legras; Laurent Macchi; Patrick Saulnier; Jean Pierre Benoit
Journal:  Int J Nanomedicine       Date:  2011-11-21

4.  Poly-ion complex (PIC) formation of heparin and polyamines: PIC with tetrakis (3-aminopropyl) ammonium allows sustained release of heparin.

Authors:  Daichi Ito; Dan Ge; Noriyuki Kogure; Hitomi Manaka; Yusuke Terui; Hiromitsu Takayama; Robert J Linhardt; Toshihiko Toida; Kyohei Higashi
Journal:  Heliyon       Date:  2020-10-06

5.  Specific intracellular uptake of herceptin-conjugated CdSe/ZnS quantum dots into breast cancer cells.

Authors:  Seung-Jin Han; Pierson Rathinaraj; Soo-Young Park; Young Kyoo Kim; Joon Hyung Lee; Inn-Kyu Kang; Jong-Sik Moon; Jeffrey G Winiarz
Journal:  Biomed Res Int       Date:  2014-01-09       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.